Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl

Eur J Pharm Biopharm. 2003 May;55(3):339-44. doi: 10.1016/s0939-6411(03)00022-5.


Metoclopramide HCl showed controlled release behavior when embedded in a hydrophilic matrix of chitosan and sodium alginate. The in vitro release data was found to be first order according to the Higuchi mechanism. An in vivo evaluation of the metoclopramide controlled release matrix on six male volunteers was carried out. The plasma samples were analyzed using a high-performance liquid chromatography (HPLC) method using a mobile phase of acetonitrile:acetic acid (30:70), with the pH adjusted to 4.7, a reverse phase Hypersil BDS Phenyl column (4 microm, 250 x 4 mm) and the detection was performed at 305 nm. The controlled release formula was found to be effective in delaying absorption (t(max) 4.5h as compared to 1.2h), reducing the peak plasma concentrations (C(max) 63.4 ng/ml as compared to 95.9 ng/ml) and maintaining higher concentrations during the elimination phase when compared to the immediate release formula. This proves the suitability of the suggested system for further studies.

MeSH terms

  • Adult
  • Chemistry, Pharmaceutical
  • Confidence Intervals
  • Cross-Over Studies
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Humans
  • Male
  • Metoclopramide / blood*
  • Metoclopramide / chemistry
  • Metoclopramide / pharmacokinetics*
  • Polymers / chemistry
  • Polymers / pharmacokinetics*


  • Delayed-Action Preparations
  • Polymers
  • Metoclopramide